Skip to main content
Article thumbnail
Location of Repository

The relative effects of leukocyte depletion and nitric oxide modulation in an ex-vivo porcine normothermic perfusion model of donation after cardiac death in the kidney

By Phillip James Yates


Introduction: The shortage of donors necessitates the use of organs from donation after cardiac death (DCD) donors. These organs demonstrate a high rate of delayed graft function (DGF) and primary non-function (PNF) when compared to those from non-DCD donors. DGF and PNF are associated with shorter graft survival times. Reperfusion injury (RI) is important in the aetiology of DGF and PNF. The roles of leukocytes and nitric oxide (NO) are pivotal in the generation of RI. \ud The aim of this study was to assess the effect on RI of modulating leukocyte and NO levels at the time of reperfusion. \ud Methods: This study utilised a porcine extra-corporeal normothermic perfusion model of RI. Kidneys were perfused with whole (WB) or leukocyte depleted blood (LDB) alone, or with an inducible nitric oxide (iNOS) inhibitor or NO donor. This model allows the collection of haemodynamic and functional data, as well as plasma and urine for biochemical analysis. \ud Results: Kidneys reperfused with LDB demonstrated improved blood flow and function compared to those reperfused with WB. \ud Initial blood flow and function in the iNOS supplemented groups was worse than in the WB/LDB perfused groups, but improved in the NO donor groups. Late blood flow plateaued in the NO donor groups but improved in the iNOS supplemented WB group. LDB and iNOS supplementation together gave poor blood flow and function throughout reperfusion. \ud Conclusion: Depletion of leukocytes abrogates the no-reflow phenomenon and reduces the oxidative stress caused by white cell infiltration, thereby improving blood flow and function. \ud The effects of nitric oxide and its inhibition on the endothelium, glomerulus and renal tubule during initial reperfusion are dependent upon the phase of reperfusion. Early benefits to blood flow by NO supplementation are offset by the generation of NO free radicals later after reperfusion

Publisher: University of Leicester
Year: 2010
OAI identifier:

Suggested articles


  1. (1997). 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo.
  2. 24-hour and 72-hour preservation of canine kidneys.
  3. (2000). A comparison of the results of renal transplantation from non-heart-beating, conventional cadaveric, and living donors. Kidney International.
  4. (2004). A comparison of traditional open, minimal-incision donor nephrectomy and laparoscopic donor nephrectomy. Transplant International.
  5. (2000). a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell.
  6. (2002). A model of isolated autologously hemoperfused porcine slaughterhouse kidneys. Nephron.
  7. (2002). A paired study comparing the efficacy of renal preservation by normothermic autologous blood perfusion and hypothermic pulsatile perfusion. Transplantation Proceedings.
  8. (1990). A series of prostaglandin F2-like compounds are produced in vivo in humans by a noncyclooxygenase, free radical-catalyzed mechanism.
  9. (2001). A subpopulation of mitochondria prevents cytosolic calcium overload in endothelial cells after cold ischemia/reperfusion. Transplantation.
  10. (2000). A useful predictor in machine perfusion preservation for kidney transplantation from non-heart-beating donors. Transplantation Proceedings.
  11. (1996). ABC of Brain Stem Death. 2nd edn.
  12. (2004). Actin cytoskeleton in ischemic acute renal failure. Kidney International.
  13. (2003). Activation of mitochondrial apoptotic pathways in human renal allografts after ischemiareperfusion injury. Transplantation.
  14. (2005). Acute renal failure. Lancet.
  15. (2005). Acute tubular necrosis is characterized by activation of the alternative pathway of complement. Kidney International.
  16. (2007). Adhesion and signaling molecules controlling the transmigration of leukocytes through endothelium. Immunological Reviews.
  17. (1993). Altered pulmonary microvascular reactivity after total cardiopulmonary bypass.
  18. (1994). Alternative pathway activation of complement by cultured human proximal tubular epithelial cells. Kidney International.
  19. (1983). An analysis of the optimal conditions for perfusing an isolated rabbit kidney with homologous blood. Renal Physiology.
  20. (1996). An automated and portable low-flow pulsatile perfusion system for organ preservation. Transplant International.
  21. (2002). Anti-c5a ameliorates coagulation/fibrinolytic protein changes in a rat model of sepsis.
  22. (1994). Antibody to intercellular adhesion molecule 1 protects the kidney against ischemic injury.
  23. (2004). Apoptosis in ischemic renal injury: roles of GTP depletion and p53. Kidney International.
  24. (1999). Apoptosis inducing factor (AIF): a phylogenetically old, caspase-independent effector of cell death.
  25. (2004). Apoptotic pathways in ischemic acute renal failure. Kidney Int.
  26. (2008). Application of nitric oxide and carbon monoxide in a model of renal preservation.
  27. (1998). Bax-induced cytochrome C release from mitochondria is independent of the permeability transition pore but highly dependent on Mg2+ ions.
  28. (1981). Biochemical Heterogenicity and Site-Specific Tubular Injury. In:
  29. (2005). Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning? Free Radical Biology
  30. (2002). Calcium and oxidative stress: from cell signaling to cell death. Molecular Immunology.
  31. (1990). Calcium in renal cells. Modulation of calcium-dependent activation of phospholipase A2. Environmental Health Perspectives.
  32. (2000). Calpain and caspase: can you tell the difference? Trends in Neurosciences.
  33. (2008). Carbon monoxide protects against ischemia-reperfusion injury in an experimental model of controlled nonheartbeating donor kidney. Transplantation.
  34. (1994). Cardiac preservation is enhanced in a heterotopic rat transplant model by supplementing the nitric oxide pathway.
  35. (2003). Cardiovascular and renal control in NOSdeficient mouse models.
  36. (1995). Categories of non-heart-beating donors. Transplantation Proceedings.
  37. (2003). Cell death induced by acute renal injury: a perspective on the contributions of apoptosis and necrosis.
  38. (1997). Characterization of bovine endothelial nitric oxide synthase as a homodimer with down-regulated uncoupled NADPH oxidase activity: tetrahydrobiopterin binding kinetics and role of haem in dimerization. Biochemical Journal.
  39. (2000). chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies.
  40. (1985). Chemotactic responses of human peripheral blood monocytes to the complement-derived peptides C5a and C5a des Arg. Journal of Immunology.
  41. (2005). Clinical results from transplanting incompatible live kidney donor/recipient pairs using kidney paired donation. JAMA.
  42. (1976). Comparative evaluation of fractional excretion of sodium following saline infusion in transplanted kidneys and in isolated perfused kidneys in conditions of previous high or low dietary sodium intake. Pflugers Archiv -European Journal of Physiology.
  43. (1986). Comparison of 51Cr EDTA clearance with formulae in the measurement of glomerular filtration rate. Pathology.
  44. Complement factor C5a mediates renal ischemia-reperfusion injury independent from neutrophils.
  45. (2000). Consensus statement on the live organ donor.[see
  46. (2003). Contrasting roles for STAT4 and STAT6 signal transduction pathways in murine renal ischemia-reperfusion injury.
  47. (2005). Council of the Transplantation S, Delmonico F. A Report of the Amsterdam Forum On the Care of the Live Kidney Donor: Data and Medical Guidelines. Transplantation.
  48. (1996). Cytosolic phospholipase A2 (PLA2), but not secretory PLA2, potentiates hydrogen peroxide cytotoxicity in kidney epithelial cells.
  49. (2004). Delayed graft function in kidney transplantation. The Lancet.
  50. (1997). Delayed graft function: risk factors and implications for renal allograft survival. Transplantation.
  51. (1996). Determinants of chronic renal allograft rejection in cyclosporine-treated recipients. Transplantation.
  52. (1991). Detrimental effect of acute renal failure on the survival of renal allografts: influence of total ischaemia time and anastomosis time. Nephrology Dialysis Transplantation.
  53. (1969). Development of an isolated perfused dog kidney with improved function.
  54. (2007). Diagnostic Performance of Fractional Excretion of Urea and Fractional Excretion of Sodium in the Evaluations of Patients With Acute Kidney Injury With or Without Diuretic Treatment. American Journal of Kidney Diseases.
  55. (1996). Differential cytoprotection by glycine against oxidant damage to proximal tubule cells. Kidney International.
  56. (2007). Differential expression of cytoprotective and apoptotic genes in an ischaemia-reperfusion isolated organ perfusion model of the transplanted kidney. Transplant International.
  57. (2003). Differential expression of heme oxygenase-1 and vascular endothelial growth factor in cadaveric and living donor kidneys after ischemia-reperfusion.
  58. (2003). Differential gene expression following early renal ischemia/reperfusion. Kidney International.
  59. (1999). Duality of nitric oxide in acute renal injury. Seminars in Nephrology.
  60. (2003). Effect of cardiopulmonary bypass on urea cycle intermediates and nitric oxide levels after congenital heart surgery. Journal of Pediatrics.
  61. (2008). Effect of ischemia-reperfusion on renal expression and activity of N(G)-N(G)-dimethylarginine dimethylaminohydrolases. Anesthesiology.
  62. Effect of nitric oxide on the contractile function of rat reperfused skeletal muscle.
  63. (1996). Effect of reactive oxygen species on endothelin-1 production by human mesangial cells. Kidney International.
  64. (2006). Effects of arterial pressure in an experimental isolated haemoperfused porcine kidney preservation system.
  65. (2008). Effects of erythropoietin on ischaemia/reperfusion injury in a controlled nonheart beating donor kidney model. Transplant International.
  66. (1980). Effects of hypothermia on canine kidney mitochondria. Cryobiology.
  67. (1997). Endothelin in ischemic acute renal failure.
  68. (1999). Enzymatic function of nitric oxide synthases. Cardiovascular Research.
  69. (1998). Enzymology of nitric oxide synthases.
  70. (2002). Essential role of the C5a receptor in E coli-induced oxidative burst and phagocytosis revealed by a novel lepirudinbased human whole blood model of inflammation.[erratum appears in Blood
  71. (1997). Ex vivo resuscitation of kidneys after postmortem warm ischemia.
  72. (2004). Exchanging kidneys--advances in living-donor transplantation.[see comment].
  73. (1955). Experiences with renal homotransplantation in the human: report of nine cases.
  74. (1972). Experimental and clinical results of continuous hypothermic albumin perfusion.
  75. (2008). Experimental renal preservation by normothermic resuscitation perfusion with autologous blood.
  76. (2007). Experimental strategies to improve in vitro models of renal ischemia. Experimental and Molecular Pathology.
  77. (2002). Expression and function of C5a receptor in mouse microvascular endothelial cells.
  78. (2001). Expression of an endothelialtype nitric oxide synthase isoform in human neutrophils: modification by tumor necrosis factor-alpha and during acute myocardial infarction.
  79. (1998). Expression of CD27 and ischemia/reperfusion-induced expression of its ligand Siva in rat kidneys. Kidney International.
  80. (1995). Expression of constitutive endothelial nitric oxide synthase in human blood platelets. Life Sciences.
  81. (2002). Failure of BCL-2 up-regulation in proximal tubular epithelial cells of donor kidney biopsy specimens is associated with apoptosis and delayed graft function. Laboratory Investigation.
  82. (1994). Free radicals in diabetic endothelial cell dysfunction.
  83. (2001). Glomerular Filtration and Renal Blood Flow.
  84. (1996). Glyoxalase II and glutathione levels in rat liver mitochondria during cold storage
  85. (2001). Guanosine supplementation reduces apoptosis and protects renal function in the setting of ischemic injury.
  86. Hypothermia--a limiting factor in using warm ischemically damaged kidneys.
  87. (1999). Hypoxia induces renal tubular epithelial cell apoptosis in chronic renal disease. Laboratory Investigation.
  88. (2000). Identification and kinetics of leukocytes after severe ischaemia/reperfusion renal injury. Nephrology Dialysis Transplantation.
  89. (2000). II: Ex vivo viability testing of kidneys after postmortem warm ischemia.
  90. (1996). Immediate function and cost comparison between static and pulsatile preservation in kidney recipients. Clinical Transplantation.
  91. (1995). Immunological characterization of urinary 8-epi-prostaglandin F2 alpha excretion in man. J Pharmacol Exp Ther.
  92. (1996). Impact of first acute rejection episode and severity of rejection on cadaveric renal allograft survival. Clinical Transplantation.
  93. (2000). Improved outcomes in cadaveric renal allografts with pulsatile preservation. Clinical Transplantation.
  94. (2007). In situ preservation of kidneys from donors after cardiac death: results and complications. Annals of Surgery.
  95. (1993). Increase in bleomycin-detectable iron in ischaemia/reperfusion injury to rat kidneys. Biochemical Journal.
  96. (1999). Increased nitric oxide synthase activity after canine cardiopulmonary bypass is suppressed by snitrosoglutathione.
  97. (2000). Increased rates of donation with laparoscopic donor nephrectomy. Annals of Surgery.
  98. (2005). Inducible nitric oxide synthase inhibition improves intestinal microcirculatory oxygenation and CO2 balance during endotoxemia in pigs. Intensive Care Medicine.
  99. (1998). Inducible nitric-oxide synthase generates superoxide from the reductase domain.
  100. (1996). Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome
  101. (2004). Inflammatory cells in ischemic acute renal failure. Kidney Int.
  102. (2004). Inhibition of inducible nitric oxide synthase and superoxide production reduces matrix metalloproteinase-9 activity and restores coronary vasomotor function in rat cardiac allografts. European Journal of Cardio-Thoracic Surgery.
  103. Inhibition of nitric oxide synthase reduces renal ischemia/reperfusion injury.
  104. (1999). Inhibitors of poly (ADP-ribose) synthetase protect rat proximal tubular cells against oxidant stress. Kidney International.
  105. (2003). Injury of the renal microvascular endothelium alters barrier function after ischemia.
  106. (2001). Interspecies differences in hepatic Ca(2+)-ATPase activity and the effect of cold preservation on porcine liver Ca(2+)-ATPase function. Liver Transplantation.
  107. (2002). Ischemia induces alterations in actin filaments in renal vascular smooth muscle cells.
  108. (2004). Ischemic acute renal failure: An inflammatory disease? Kidney Int.
  109. (1969). Kidney preservation for transportation. Initial perfusion and 30 hours' ice storage. Lancet.
  110. (1999). Kidney preservation in the next millenium. Transplant International.
  111. (2003). Kidney transplantation from non heart-beating donors.
  112. (2005). Kidney transplantation from non-heart-beating donors after oxygenated low-flow machine perfusion preservation with histidine-tryptophan-ketoglutarate solution. Transplant International.
  113. Lack of a functional alternative complement pathway ameliorates ischemic acute renal failure in mice.
  114. (2008). Laparoscopic versus open live donor nephrectomy in renal transplantation: a meta-analysis.[see comment]. Annals of Surgery.
  115. (1959). Le coma depasse (memoire preliminaire). Revue Neurologique.
  116. (2006). Leucocyte depletion improves renal function during reperfusion using an experimental isolated haemoperfused organ preservation system.
  117. (1995). Leucocyte-endothelial cell adhesion in a model of intestinal inflammation.
  118. (2004). Leukocyte recruitment and acute renal failure.
  119. (2000). Leukocytes and endothelium interaction as rate limiting step in the inflammatory response and a key factor in the ischemiareperfusion injury. Annals of Transplantation.
  120. (1998). Long-term renal function in on-heartbeating donor kidney transplantation: a single-center experience. Transplantation.
  121. (2009). Machine Perfusion or Cold Storage in Deceased-Donor Kidney Transplantation.
  122. (1993). Macrophage nitric oxide synthase subunits. Purification, characterization, and role of prosthetic groups and substrate in regulating their association into a dimeric enzyme.
  123. (2008). Marked variation in the definition and diagnosis of delayed graft function: a systematic review. Nephrol Dial Transplant.
  124. (1999). Mass spectrometric quantification of F2-isoprostanes in biological fluids and tissues as measure of oxidant stress. Methods in Enzymology.
  125. (1990). Measurement of renal function in chronic renal disease. Kidney International.
  126. (1998). Mechanisms of cell death in hypoxia/reoxygenation injury. Oncogene.
  127. (2003). Mechanisms of inducible nitric oxide synthase (iNOS) inhibition-related improvement of gut mucosal acidosis during hyperdynamic porcine endotoxemia. Intensive Care Medicine.
  128. Mechanisms of oxidant-mediated cell injury. The glycolytic and mitochondrial pathways of ADP phosphorylation 9:
  129. (1988). Metabolic and functional consequences of inhibiting adenosine deaminase during renal ischemia in rats.
  130. (1996). Metabolic basis of ion transport.
  131. (1999). Mitochondria and cell death. Mechanistic aspects and methodological issues.
  132. Mitochondrial calcium uptake regulates cold preservation-induced Bax translocation and early reperfusion apoptosis.
  133. (2000). Mitochondrial control of cell death. Nature Medicine.
  134. (2000). Modeling ischemia in vitro: selective depletion of adenine and guanine nucleotide pools.
  135. (2002). Modulation of chemokine production and expression of adhesion molecules in renal tubular epithelial and endothelial cells by catecholamines. Transplantation.
  136. (1994). Modulation of ischemia/reperfusion-induced microvascular dysfunction by nitric oxide. Circulation Research.
  137. (1998). Neutrophils and acute ischemiareperfusion injury.
  138. (1999). Neutrophils and renal failure.
  139. Nitric oxide and skeletal muscle reperfusion injury: current controversies (research review).
  140. (1993). Nitric oxide prevents leukocyte adherence: role of superoxide.
  141. (2003). Nitric oxide, superoxide, and peroxynitrite in myocardial ischaemia-reperfusion injury and preconditioning.
  142. (1996). Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly.
  143. (2006). NO and NOS isoforms in the development of apoptosis in renal ischemia/reperfusion. Free Radical Biology & Medicine.
  144. (1994). NO donors prevent integrin-induced leukocyte adhesion but not P-selectin-dependent rolling in postischemic venules.
  145. (2007). Non-heartbeating donation of kidneys for transplantation. Nature Clinical Practice Nephrology.
  146. (2003). Nonheart-beating kidney donation: current practice and future developments. Kidney International.
  147. (1994). Nonheartbeating cadaveric organ donation. Annals of Surgery.
  148. (2000). Normothermic blood perfusion of isolated rabbit kidneys. II. In vitro evaluation of renal function followed by orthotopic transplantation.
  149. (2002). Normothermic blood perfusion of isolated rabbit kidneys. III.
  150. (2007). Outcome of kidney transplantation from nonheart-beating versus heart-beating cadaveric donors. Transplantation.
  151. (1995). Outcome of transplantation of non-heart-beating donor kidneys. Lancet.
  152. (2002). Overcoming severe renal ischemia: the role of ex vivo warm perfusion. Transplantation.
  153. (1986). Oxidant injury of cells. DNA strand-breaks activate polyadenosine diphosphate-ribose polymerase and lead to depletion of nicotinamide adenine dinucleotide. Journal of Clinical Investigation.
  154. Oxidant stress regulation of IL-8 and ICAM-1 gene expression: differential activation and binding of the transcription factors AP-1 and NFkappaB.
  155. (1985). Oxidants increase paracellular permeability in a cultured epithelial cell line.
  156. (1992). Oxidative stress and cytoskeletal alterations. Annals of the New York Academy of Sciences.
  157. (1993). Oxidative stress causes a protein kinase C-independent increase of paracellular permeability in an in vitro epithelial model.
  158. (1999). Oxygen is a toxic gas - an introduction to oxygen toxicity and reactive oxgyen species.
  159. (2001). p38 MAPK mediates renal tubular cell TNF-alpha production and TNF-alpha-dependent apoptosis during simulated ischemia.
  160. (1999). Partial ATP depletion induces Fas- and caspase-mediated apoptosis in MDCK cells.
  161. (2000). Pathophysiological role of T lymphocytes in renal ischemia-reperfusion injury in mice.
  162. (2003). Perioperative blood pressure control, delayed graft function, and acute rejection after renal transplantation. Transplantation.
  163. (1997). Peripheral blood chimerism following human liver transplantation. Hepatology.
  164. (2007). Peroxynitrite: biochemistry, pathophysiology and development of therapeutics. Nature Reviews Drug Discovery.
  165. (1998). Platelet-endothelial cell interactions during ischemia/reperfusion: the role of P-selectin.
  166. (2000). Predominant role for C5b-9 in renal ischemia/reperfusion injury.
  167. (1997). Prevention of late renal changes after initial ischemia/reperfusion injury by blocking early selectin binding. Transplantation.
  168. (2000). Prevention of renal impairment following aortic cross-clamping by manipulation of the endogenous renal nitric oxide response.
  169. (2000). Production and functional roles of nitric oxide in the proximal tubule.
  170. (2000). Protection of autotransplanted pig kidneys from ischemia-reperfusion injury by polyethylene glycol. Transplantation.
  171. (2002). Protective effect of T cell depletion in murine renal ischemia-reperfusion injury. Transplantation.
  172. (1994). Pulsatile kidney perfusion for evaluation of high-risk kidney donors safely expands the donor pool. Clinical Transplantation.
  173. (2005). Pulsatile machine perfusion with Vasosol solution improves early graft function after cadaveric renal transplantation.[retraction in Stubenbord
  174. (2000). Reactive oxygen species and acute renal failure.
  175. (2005). Recent advances in the biochemistry and clinical relevance of the isoprostane pathway. Lipids.
  176. Recipient hemodynamics during non-heart-beating donor kidney transplantation are major predictors of primary nonfunction.
  177. (1999). Reduction of lung allograft ischemia/reperfusion injury by tetrahydrobiopterin coenzyme of NOS. Transplantation Proceedings.
  178. (1995). Regeneration of ATP in kidney slices after warm ischemia and hypothermic preservation. Transplant International.
  179. (1997). Regulation of the mitochondrial Ca2+ uniporter by external adenine nucleotides: the uniporter behaves like a gated channel which is regulated by nucleotides and divalent cations. Biochemistry.
  180. (2007). Renal effects of nitric oxide during sepsis: another two-edged sword?[comment].
  181. (1981). Renal hemodynamics and oxygen consumption during postischemic acute renal failure in the rat. Kidney International.
  182. (2001). Renal ischemia in the rat stimulates glomerular nitric oxide synthesis.
  183. (2005). Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: role of macrophages.
  184. (1998). Renal ischemia-reperfusion injury: contribution of nitric oxide and renal
  185. (2005). Renal ischemia/reperfusion injury: functional tissue preservation by anti-activated {beta}1 integrin therapy.
  186. (2002). Renal transplantations performed using non-heart-beating organ donors: going back to the future? Transplantation.
  187. Repair of damaged organs in vitro.
  188. (2003). Reperfusion injury is reduced in skeletal muscle by inhibition of inducible nitric oxide synthase.
  189. (1999). Review article: the role of tumor necrosis factor in renal ischemia-reperfusion injury. Journal of Urology.
  190. (1997). Role of caspases (ICE/CED 3 proteases) in DNA damage and cell death in response to a mitochondrial inhibitor, antimycin A. Kidney International.
  191. (1999). Role of caspases in hypoxia-induced necrosis of rat renal proximal tubules.
  192. (1998). Role of hypoxia-induced Bax translocation and cytochrome c release in reoxygenation injury. Oncogene.
  193. (2002). S-nitroso human serum albumin treatment reduces ischemia/reperfusion injury in skeletal muscle via nitric oxide release. Circulation.
  194. (1992). Serum creatinine as an index of renal function: new insights into old concepts.[see comment]. Clinical Chemistry.
  195. (2002). Simulated ischemia induces renal tubular cell apoptosis through a nuclear factor-kappaB dependent mechanism.
  196. (1984). Six-day canine kidney preservation. Hypothermic perfusion combined with isolated blood perfusion. Transplantation.
  197. (1999). Stimulus-specific regulation of chemokine expression involves differential activation of the redox-responsive transcription factors AP-1 and NF-kappaB.
  198. (1997). Strategy for eliminating the kidney shortage. Clinical Transplants.
  199. (1997). Sublytic concentrations of the membrane attack complex of complement induce endothelial interleukin-8 and monocyte chemoattractant protein-1 through nuclear factor-kappa B activation.
  200. (1997). Subunit interactions of endothelial nitric-oxide synthase. Comparisons to the neuronal and inducible nitric-oxide synthase isoforms.
  201. (1956). Successful homotransplantation of the human kidney between identical twins.
  202. (1966). Successful storage of kidneys.
  203. (1996). Superoxide anion and endothelial regulation of arterial tone.
  204. (1998). Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors.
  205. (2004). T cells as mediators in renal ischemia-reperfusion injury. Kidney Int.
  206. (1998). Tetrahydrobiopterin alters superoxide and nitric oxide release in prehypertensive rats.
  207. (2004). The alternative pathway of complement in disease: opportunities for therapeutic targeting. Molecular Immunology.
  208. (1991). The cell biology of ischemic renal injury. Kidney Int.
  209. (2002). The Ceramide-centric Universe of Lipid-mediated Cell Regulation: Stress Encounters of the Lipid Kind.
  210. (1997). The cytokineadhesion molecule cascade in ischemia/reperfusion injury of the rat kidney. Inhibition by a soluble P-selectin ligand.
  211. (2008). The effect of warm ischemic time on renal function and injury in the isolated hemoperfused kidney. Transplantation.
  212. (1999). The Fas ligand/Fas system in renal injury. Nephrology Dialysis Transplantation.
  213. (2000). The influence of pulsatile preservation on renal transplantation in the 1990s. Transplantation.
  214. (1999). The involvement of oxidative stress in the progression of renal injury. Blood Purification.
  215. (1997). The isoprostanes: a perspective. Prostaglandins.
  216. (1997). The isoprostanes: unique bioactive products of lipid peroxidation.
  217. (1996). The isoprostanes. Current knowledge and directions for future research. Biochemical Pharmacology.
  218. (2004). The mannose-binding lectinpathway is involved in complement activation in the course of renal ischemiareperfusion injury.
  219. (2001). The morphologic basis of acute renal failure.
  220. The postmortem survival of tissues: A standardized glucose oxidation procedure for assessing tissue viability after death of the host.
  221. (1997). The potential pool of nonheart-beating kidney donors. Clinical Transplantation.
  222. (2008). The relative effects of warm and cold ischemic injury in an experimental model of nonheartbeating donor kidneys. Transplantation.
  223. (1990). The role of calcium in lethal cell injury. Chemical Research in Toxicology.
  224. (2004). The role of mitochondria in ischemia-reperfusion injury in organ transplantation. Kidney Int.
  225. (1997). Through and beyond the wall: late steps in leukocyte transendothelial migration. Immunology Today.
  226. (1997). Timing of administration of dexamethasone or the nitric oxide synthase inhibitor, nitro-L-arginine methyl ester, is critical for effective treatment of ischaemia-reperfusion injury to rat skeletal muscle. Clinical Science.
  227. (2008). Transplant activity in the UK. UK Transplant,
  228. (1998). Transplantation of kidneys from donors whose hearts have stopped beating. New England Journal of Medicine.
  229. (2007). UK Renal Registry Report. The Renal Association,
  230. (2006). Update on mechanisms of ischemic acute kidney injury.
  231. Upregulation of renal inducible nitric oxide synthase during human endotoxemia and sepsis is associated with proximal tubule injury.
  232. Utilizing list exchange and nondirected donation through 'chain' paired kidney donations.
  233. (1997). Warm ex vivo perfusion prevents reperfusion injury in warm ischemically damaged kidneys. Transplantation Proceedings.
  234. (1996). Work-load generated by the establishment of a non-heart beating kidney transplant programme. Transplant International.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.